4 Results for "

FAP-expressing cells

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "FAP-expressing cells" in MCE Product Catalog:

Cat. No.: HY-139401
CAS No.: 2374782-07-5
Purity:  99.67%
Target:  

FAP

Research Areas:  

Cancer

FAPI-34 is a SPECT imaging agent targeting FAP. FAPI-34 specifically binds to FAP, is highly internalized by FAP-expressing cells, accumulates in FAP-expressing tumor lesions, and shows low uptake in normal tissues except the kidneys. FAPI-34 is applicable for tumor-related research .
loading...
    loading...
Cat. No.: HY-145358
CAS No.: 2415941-98-7
Target:  

PI3K

Research Areas:  

Cancer

FAP-PI3KI1 is a fibroblast-activated protein (FAP)-targeted PI3K inhibitor that selectively targets FAP-expressing human idiopathic pulmonary fibrosis (IPF) cells and effectively inhibits collagen synthesis and reduces collagen deposition .
loading...
    loading...
Cat. No.: HY-W668749
CAS No.: 2374782-82-6
Target:  

FAP

Research Areas:  

Inflammation/Immunology

3BP-3580 (compound 11) is a conjugate targeting FAP that binds to FAP-positive cells via the FAPI moiety and internalizes, delivering the payload to FAP-expressing cells, thereby inhibiting RA FLS proliferation, migration, and invasion, reducing inflammatory cytokine expression, and suppressing pannus formation. 3BP-3580 can be used for research on rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-P11602
CAS No.: 3107530-08-2
Target:  

FAP

Research Areas:  

Cancer

DOTA-C1-FAP-2286 is a cysteic acid-modified fibroblast activation protein (FAP)-targeting radioligand. DOTA-C1-FAP-2286 binds competitively to FAP with an IC50 of 127.64 nM. DOTA-C1-FAP-2286 is targeted accumulation in FAP-expressing cells and exhibits accelerated renal clearance. DOTA-C1-FAP-2286 can be used as a PET/CT tracer in cancer .
loading...
    loading...